Lipschütz Ulcer and SARS-CoV-2: What We Currently Know?

Background: In recent years, several interesting case reports have been published which describe the possible role of SARS-CoV-2 infection or vaccination in the etiopathogenesis of Lipschütz ulcer. Our aim is to analyze this association and provide a rapid algorithm that is of support to gynecologis...

Full description

Bibliographic Details
Main Authors: Lucia Merlino, Agnese Immacolata Volpicelli, Mattia Dominoni, Marianna Francesca Pasquali, Giulia D’Ovidio, Barbara Gardella, Roberto Senatori
Format: Article
Language:English
Published: MDPI AG 2023-09-01
Series:Diseases
Subjects:
Online Access:https://www.mdpi.com/2079-9721/11/3/121
_version_ 1827726565593579520
author Lucia Merlino
Agnese Immacolata Volpicelli
Mattia Dominoni
Marianna Francesca Pasquali
Giulia D’Ovidio
Barbara Gardella
Roberto Senatori
author_facet Lucia Merlino
Agnese Immacolata Volpicelli
Mattia Dominoni
Marianna Francesca Pasquali
Giulia D’Ovidio
Barbara Gardella
Roberto Senatori
author_sort Lucia Merlino
collection DOAJ
description Background: In recent years, several interesting case reports have been published which describe the possible role of SARS-CoV-2 infection or vaccination in the etiopathogenesis of Lipschütz ulcer. Our aim is to analyze this association and provide a rapid algorithm that is of support to gynecologists and dermatologists both in the diagnosis and in setting up the therapy. To do so, in this paper, we describe an interesting case of acute vulvar ulcer triggered by SARS-CoV-2 infection and review the related literature. Methods: We conducted a literature review including papers published between October 2021 and April 2023, and we described the case of a patient referred to our clinic with Lipschütz ulcer and SARS-CoV-2 infection. Results: In almost all cases analyzed, a correlation with SARS-CoV-2 infection or vaccination was found; ulcers usually manifest after 2 to 4 weeks and are associated with flu-like symptoms. A concordance in review papers, as well as in our case report, was also found about the treatment, which is mainly symptomatic. Conclusions: Previous infection or vaccination for SARS-CoV-2 should be included as possible etiopathogenetic factors in the onset of Lipschütz ulcer.
first_indexed 2024-03-10T22:52:37Z
format Article
id doaj.art-e0b82f72dbc1404d9979de9619bbc1ef
institution Directory Open Access Journal
issn 2079-9721
language English
last_indexed 2024-03-10T22:52:37Z
publishDate 2023-09-01
publisher MDPI AG
record_format Article
series Diseases
spelling doaj.art-e0b82f72dbc1404d9979de9619bbc1ef2023-11-19T10:15:33ZengMDPI AGDiseases2079-97212023-09-0111312110.3390/diseases11030121Lipschütz Ulcer and SARS-CoV-2: What We Currently Know?Lucia Merlino0Agnese Immacolata Volpicelli1Mattia Dominoni2Marianna Francesca Pasquali3Giulia D’Ovidio4Barbara Gardella5Roberto Senatori6Department of Medical-Surgical Sciences and Biotechnologies, Sapeinza University of Rome, 00161 Rome, ItalyDepartment of Medical-Surgical Sciences and Biotechnologies, Sapeinza University of Rome, 00161 Rome, ItalyDepartment of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, ItalyDepartment of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, ItalyDepartment of Medical-Surgical Sciences and Biotechnologies, Sapeinza University of Rome, 00161 Rome, ItalyDepartment of Clinical, Surgical, Diagnostic and Paediatric Sciences, University of Pavia, 27100 Pavia, ItalyItalian Society of Colposcopy and Cervicovaginal Pathology (SICPV), 00186 Rome, ItalyBackground: In recent years, several interesting case reports have been published which describe the possible role of SARS-CoV-2 infection or vaccination in the etiopathogenesis of Lipschütz ulcer. Our aim is to analyze this association and provide a rapid algorithm that is of support to gynecologists and dermatologists both in the diagnosis and in setting up the therapy. To do so, in this paper, we describe an interesting case of acute vulvar ulcer triggered by SARS-CoV-2 infection and review the related literature. Methods: We conducted a literature review including papers published between October 2021 and April 2023, and we described the case of a patient referred to our clinic with Lipschütz ulcer and SARS-CoV-2 infection. Results: In almost all cases analyzed, a correlation with SARS-CoV-2 infection or vaccination was found; ulcers usually manifest after 2 to 4 weeks and are associated with flu-like symptoms. A concordance in review papers, as well as in our case report, was also found about the treatment, which is mainly symptomatic. Conclusions: Previous infection or vaccination for SARS-CoV-2 should be included as possible etiopathogenetic factors in the onset of Lipschütz ulcer.https://www.mdpi.com/2079-9721/11/3/121Lipschütz ulceracute vulvar ulcernon-sexually transmitted vulvar aphthosisSARS-CoV-2COVID-19
spellingShingle Lucia Merlino
Agnese Immacolata Volpicelli
Mattia Dominoni
Marianna Francesca Pasquali
Giulia D’Ovidio
Barbara Gardella
Roberto Senatori
Lipschütz Ulcer and SARS-CoV-2: What We Currently Know?
Diseases
Lipschütz ulcer
acute vulvar ulcer
non-sexually transmitted vulvar aphthosis
SARS-CoV-2
COVID-19
title Lipschütz Ulcer and SARS-CoV-2: What We Currently Know?
title_full Lipschütz Ulcer and SARS-CoV-2: What We Currently Know?
title_fullStr Lipschütz Ulcer and SARS-CoV-2: What We Currently Know?
title_full_unstemmed Lipschütz Ulcer and SARS-CoV-2: What We Currently Know?
title_short Lipschütz Ulcer and SARS-CoV-2: What We Currently Know?
title_sort lipschutz ulcer and sars cov 2 what we currently know
topic Lipschütz ulcer
acute vulvar ulcer
non-sexually transmitted vulvar aphthosis
SARS-CoV-2
COVID-19
url https://www.mdpi.com/2079-9721/11/3/121
work_keys_str_mv AT luciamerlino lipschutzulcerandsarscov2whatwecurrentlyknow
AT agneseimmacolatavolpicelli lipschutzulcerandsarscov2whatwecurrentlyknow
AT mattiadominoni lipschutzulcerandsarscov2whatwecurrentlyknow
AT mariannafrancescapasquali lipschutzulcerandsarscov2whatwecurrentlyknow
AT giuliadovidio lipschutzulcerandsarscov2whatwecurrentlyknow
AT barbaragardella lipschutzulcerandsarscov2whatwecurrentlyknow
AT robertosenatori lipschutzulcerandsarscov2whatwecurrentlyknow